Editorial
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Stem Cells. Sep 26, 2011; 3(9): 83-88
Published online Sep 26, 2011. doi: 10.4252/wjsc.v3.i9.83
Convergence of normal stem cell and cancer stem cell developmental stage: Implication for differential therapies
Shengwen Calvin Li, Katherine L Lee, Jane Luo, Jiang F Zhong, William G Loudon
Shengwen Calvin Li, Katherine L Lee, William G Loudon, Neuro-Oncology Research Laboratory, Center for Neuroscience and Stem Cell Research, Children’s Hospital of Orange County, University of California Irvine, 455 South Main Street, Orange, CA 92868, United States
Jane Luo, Beckman Coulter, Inc., 250 South Kraemer Boulevard, Brea, CA 92821, United States
Jiang F Zhong, Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States
William G Loudon, Department of Neurological Surgery, University of California Irvine, Orange, CA 92862, United States
Author contributions: Li SC drafted the manuscript; Li SC, Lee KL, Luo J, Zhong JF and Loudon WG revised the paper.
Supported by CHOC Children’s Foundation and CHOC Neuroscience Institute (to Li SC); Austin Ford Tribute Fund; and the W. M. Keck Foundation (to Li SC); Grant R21CA134391 from the National Institutes of Health, and Grant AW 0852720 from the National Science Foundation (to Zhong JF)
Correspondence to: Shengwen Calvin Li, PhD, Head, Neuro-Oncology Research Laboratory, Center for Neuroscience and Stem Cell Research, Children’s Hospital of Orange County, University of California Irvine, 455 South Main Street, Orange, CA 92868, United States. shengwel@uci.edu
Telephone: +1-714-2894964 Fax: +1-718-5164318
Received: May 28, 2011
Revised: September 16, 2011
Accepted: September 21, 2011
Published online: September 26, 2011
Core Tip